Does influenza vaccination exacerbate asthma?: Analysis of a large cohort of children with asthma

Archives of Family Medicine

Volumn 9, Issue 7, 2000, Pages 617-623

  Kramarz, P ^a   DeStefano, F ^a   Gargiullo, P M ^a   Davis, R L ^a   Chen, R T ^a   Mullooly, J P ^a   Black, S B ^a   Shinefield, H R ^a   Bohlke, K ^a   Ward, J I ^a   Marcy, M S ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; INFLUENZA VACCINE; THEOPHYLLINE DERIVATIVE;

ARTICLE; ASTHMA; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SAFETY; HUMAN; HUMAN TISSUE; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRESCHOOL CHILD; RISK FACTOR; TREATMENT OUTCOME;

EID: 0033824173     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.9.7.617     Document Type: Article

References (59)

1. Is asthma increasing?
2. The worldwide increase in the prevalence of asthma in children and young adults
3. Evidence for the increase of asthma worldwide
4. Asthma and other atopic diseases in Australian children: Australian arm of the International Study of Asthma and Allergy in Childhood
5. Respiratory symptoms and atopy in Aberdeen schoolchildren: Evidence from two surveys 25 years apart
6. Changes in asthma prevalence: Two surveys 15 years apart
7. Recent trends in the prevalence and severity of childhood asthma
8. Trends in prevalence and severity of childhood asthma
9. Trends in the hospitalization for acute childhood asthma, 1970-84
10. National trends in the morbidity and mortality of asthma in the U.S.: Prevalence, hospitalization and death from asthma over two decades: 1965-1984
11. Viral respiratory tract infection and exacerbations of asthma in adult patients
12. Association of viral and bacterial respiratory infection with exacerbations of wheezing in young asthmatic children
13. Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings
14. Rhinovirus and influenza type A infections as precipitants of asthma
15. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease
16. The relationship between upper respiratory infections and hospital admissions for asthma: A time-trend analysis
17. 1 in asthmatic children
18. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
19. Influenza
20. Missed opportunities for vaccination among children with asthma
21. Improving influenza vaccination rates in children with asthma: A test of a computerized reminder system and an analysis of factors predicting vaccination compliance
22. Does influenza immunization cause exacerbations of chronic airflow obstruction or asthma?
23. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy
24. Does influenza vaccination exacerbate asthma?
25. Immunization with killed influenza virus in children with chronic asthma
26. Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients
27. Safety of the subunit influenza vaccine in asthmatic children
28. Bronchial responsiveness and leucocyte reactivity after influenza vaccine in asthmatic patients
29. Subunit influenza vaccination in adults with asthma: Effect on clinical state, airway reactivity, and antibody response
30. Unchanged bronchial reactivity after killed influenza virus vaccine in adult asthmatics
31. Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus
32. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma
33. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States: The Vaccine Safety Datalink Team
34. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization
35. Use of an automated prescription database to identify individuals with asthma
36. The case-time-control design: Further assumptions and conditions
37. Confounding and indication for treatment in evaluation of drug treatment for hypertension
38. 2-receptor antagonists, and gastric cancer
39. Influenza vaccination in children with asthma in Health Maintenance Organizations
40. Relative incidence estimation from case series for vaccine safety evaluation
41. Case series analysis of adverse reactions to vaccines: A comparative evaluation [published erratum appears in Am J Epidemiol 1998;1165-1173]
42. Principles of epidemiological research on drug effects
43. Acute respiratory infection, influenza vaccination and airway reactivity in asthma
44. Effects of killed and live attenuated influenza vaccine on symptoms and specific airway conductance in asthmatics and healthy subjects
45. Influenza vaccination in patients with asthma: Effect on peak expiratory flow, asthma symptoms and use of medication
46. Influenza vaccination in asthma
47. Influenza and asthma
48. Increased response of asthmatic subjects to methacholine after influenza vaccine
49. Safety of influenza vaccination in adults with asthma
50. Quality of HMO vaccination databases used to monitor childhood vaccine safety: Vaccine Safety DataLink Team
51. Descriptive epidemiology of asthma
52. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits
53. Hospital admissions for asthma in east London: Associations with characteristics of local general practices, prescribing, and population
54. Age-specific trends in asthma mortality in England and Wales, 1983-95: Results of an observational study
55. The use of beta-agonists and the risk of death and near death from asthma